YD Bio Ltd (YDES): Total Assets
$13.78M
As of 2025-12-31
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.78M | +100.7% | 2026-04-30, Balance as of period end |
| 2024-12-31 | $6.86M | n/a | 2026-04-30, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| YD Bio Ltd (YDES) | 2025-12-31 | $13.78M | +100.7% |
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | $101.93M | +40.5% |
| Aclarion, Inc. (ACON) | 2025-12-31 | $13.67M | +543.9% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $9.25M | -11.3% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $55.48M | -7.8% |
| CapForce Inc. (CFOR) | 2025-12-31 | $38.06M | +285.8% |
| Exagen Inc. (XGN) | 2025-12-31 | $58.02M | +29.8% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $334.16M | +23.6% |
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
Compare YDES, SERA, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗